Subsequently, we evaluated the efficacy of CWF19L1-overexpressing CTLs in targeting murine B16/F10 melanoma cells, MC38 colon carcinoma cells, and Panc02 pancreatic tumor cells pulsed with ovalbumin peptides (OVA257–264). Here, CWF19L1 is linked to colon carcinoma.